BY ED SILVERMAN: A recent study published by Biochemistry and Biophysical Research Communications found that curcumin, a component of the popular East Asian spice turmeric, is 400 times more powerful than the common diabetes drug, metformin, in improving insulin sensitivity and helping to reverse Type 2 diabetes.
Turmeric has been used as a spice in curry for centuries and recently has been touted for its extraordinary health benefits. To date there have been over 6,000 peer-reviewed research studies published proving the benefits of turmeric and specifically curcumin, one of turmeric’s highly regarded healing compounds. (read more)
BY SCIENCE DAILY: Depression in type-1 diabetes patients is associated with higher levels of the inflammatory protein galectin-3, according to research published in Endocrine Connections. These findings suggest that galectin-3 levels may be useful for diagnosis of depression or may be a new target for treating depression associated with type-1 diabetes, which could lead to better patient care.
It is well established that people with both type-1 and type-2 diabetes have an increased risk of developing depression, a debilitating mental health disorder with potentially serious consequences, but the causes remain poorly understood. Galectin-3 is a key protein involved in promoting inflammatory immune system responses that are needed to repair tissue damage throughout the body, in response to injury or disease. (read more)
BY SCIENCE DAILY: A study published in the journal Acta Diabetologica reports that people with diabetes and prediabetes who have lower sleep efficiency — a measure of how much time in bed is actually spent sleeping — have poorer cognitive function than those with better sleep efficiency.
“The cognitive effects of poor sleep quality are worse for this population, which we know is already at risk for developing cognitive impairment as a result of having diabetes,” said Dr. Sirimon Reutrakul, associate professor of endocrinology, diabetes and metabolism in the University of Illinois at Chicago College of Medicine and corresponding author on the paper. (read more)
BY BOB MOOS: If you’re on Medicare and at risk for diabetes, you’re covered for two blood sugar screenings each year at no out-of-pocket cost to you. Risk factors include high blood pressure, a history of abnormal cholesterol and triglyceride levels, obesity or a history of high blood sugar.
If you’re diagnosed with diabetes, Medicare will help pay for blood sugar self-testing equipment and supplies, as well as insulin and other anti-diabetic drugs. In the event of diabetic foot disease, it will also help pay for therapeutic shoes or inserts as long as your podiatrist prescribes them. (read more)
BY ANNA KITABJIAN: Children whose parents experienced a severe life event during the first 2 years of the child’s life may be at an increased risk for type 1 diabetes (T1D) developing later in life, according to a study published in Acta Diabetologica.
Researchers conducted a prospective study, recruiting children born between August 2000 and September 2004 in southern Sweden. Parents of children born during the selected time frame who met inclusion criteria were asked to complete a survey when their child was 2 months of age to assess the perinatal, hereditary, medical, social factors, and occurrences of severe life events during pregnancy or the first 2 months of the child’s life. (read more)